Represented Since - 2002

Amaxa is dedicated to enhance the speed and quality of basic and pharmaceutical research in academia and industry, and aspires to make a significant contribution to the development of causal therapies for the treatment of severe diseases. The company has been establishing itself as the international market leader in high-end applications for the non-viral delivery of genes and the transfer of other charged substrates into cells.